K. Williams
Claim CLM-SEP-0258 · 63 M · 4-day LOS · POS 21 · billed charge $37,800
📄 Claim as submitted
Billed DRG
871
Sepsis w/o MV >96h — WITH MCC
Pays
$13,598
A41.02Sepsis due to MRSAPDX
R65.21Severe sepsis with septic shockMCC
T80.211ABSI due to central venous catheter, initialCC
RW 1.9425 × $7,000 base · FY2026 V43.0
🩺 Medical chart
CLM-SEP-0258-seed-record.txtocr complete
63 M with stage IIIA colon cancer on cycle 4 of FOLFOX chemotherapy via tunneled PICC line, presented with 3 days of fevers, rigors, and mild confusion.
ED vitals: T 39.3°C, HR 122, BP 102/64 (one transient reading of 88/52 on arrival, responded to 500 mL NS bolus within 20 minutes), RR 22, SpO2 96% on room air. WBC 22.6, lactate 1.8 mmol/L. Mild confusion on arrival, cleared to baseline by day 2.
Peripheral blood cultures ×2: MRSA. PICC line cultures: 4/4 bottles MRSA, differential time to positivity 82 minutes — consistent with CLABSI. PICC removed on admission. No vasopressors at any point. Repeat lactate 1.4 at hour 4. BP stable after initial bolus through discharge.
IV vancomycin started. Repeat cultures day 2: negative. TEE: no vegetations.
Assessment: MRSA catheter-related bloodstream infection (CLABSI); sepsis with encephalopathy. Septic shock documented by admitting physician based on transient hypotensive episode on arrival.
🤖 Agent analysis
💬 Follow-up questions
Ask any question about this analysis — coding logic, guideline rationale, documentation gaps, or what-if scenarios.
Rate basis (FY2026 / V43.0): DRG 871 RW 1.9425 (verified CMS); DRG 872 RW 1.0299 (verified CMS FY2024); base $7,000 blended IPPS rate. Validation logic grounded in ICD-10-CM Official Guidelines §I.C.1.d, AHA Coding Clinic, UHDDS, and Sepsis-3 (Singer et al., JAMA 2016). This tool surfaces a recommendation for a human auditor and does not auto-adjudicate.